NPI: 1992721161 · MONTCLAIR, CA 91763 · General Acute Care Hospital · NPI assigned 07/14/2006
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (CHIEF COMPLINANCE COUNSEL) |
| NPI Enumeration Date | 07/14/2006 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 54,904 | $1.17M |
| 2019 | 66,655 | $1.42M |
| 2020 | 53,506 | $1.29M |
| 2021 | 66,231 | $1.62M |
| 2022 | 77,569 | $1.88M |
| 2023 | 79,031 | $2.01M |
| 2024 | 75,507 | $1.88M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 0450 | Emergency room services | 61,568 | 54,810 | $2.77M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 25,461 | 22,901 | $1.50M |
| 70450 | Computed tomography, head or brain; without contrast material | 3,267 | 3,176 | $501K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,532 | 7,889 | $494K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,562 | 3,455 | $383K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 17,367 | 15,833 | $382K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9,308 | 8,975 | $336K |
| Z7502 | 8,240 | 8,131 | $309K | |
| 80053 | Comprehensive metabolic panel | 17,496 | 16,124 | $284K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 10,357 | 9,640 | $267K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 24,005 | 21,838 | $250K |
| 99499 | 2,917 | 2,529 | $217K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,539 | 2,387 | $205K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1,451 | 1,376 | $181K |
| 96375 | Therapeutic injection; each additional sequential IV push | 6,481 | 5,814 | $163K |
| 0762 | 943 | 583 | $163K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 707 | 697 | $148K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,146 | 2,058 | $148K |
| 71045 | Radiologic examination, chest; single view | 12,073 | 11,515 | $147K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,638 | 5,993 | $120K |
| 81025 | 17,624 | 16,257 | $119K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10,627 | 8,061 | $87K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,462 | 1,430 | $86K |
| 99070 | 23,178 | 14,803 | $85K | |
| 83690 | 8,776 | 8,205 | $84K | |
| 99199 | Unlisted special service, procedure or report | 1,847 | 1,690 | $80K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,394 | 1,350 | $80K |
| 84484 | 6,264 | 5,559 | $78K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,276 | 4,972 | $68K |
| J3490 | Unclassified drugs | 14,317 | 8,980 | $59K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 6,585 | 6,290 | $56K |
| 81002 | 13,131 | 12,501 | $55K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,763 | 2,526 | $53K |
| 83880 | 2,275 | 2,170 | $53K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,329 | 1,215 | $49K |
| 81001 | 9,118 | 8,664 | $46K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 315 | 308 | $46K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 892 | 867 | $42K |
| 73610 | 1,512 | 1,469 | $41K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 490 | 464 | $36K |
| 73630 | 1,398 | 1,338 | $35K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 16,785 | 15,496 | $34K |
| 84702 | 2,074 | 1,843 | $33K | |
| 0370 | 257 | 182 | $32K | |
| 73130 | 1,127 | 1,089 | $30K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,108 | 1,071 | $30K |
| 90715 | 911 | 892 | $29K | |
| 87040 | 2,272 | 1,780 | $29K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 994 | 962 | $27K |
| J7030 | Infusion, normal saline solution , 1000 cc | 7,001 | 6,294 | $25K |
| 80076 | 1,930 | 1,855 | $24K | |
| 83605 | 1,759 | 1,595 | $23K | |
| Z9725 | 778 | 775 | $23K | |
| 73110 | 840 | 807 | $23K | |
| G0378 | Hospital observation service, per hour | 352 | 242 | $23K |
| 73030 | 885 | 840 | $23K | |
| 80305 | 2,074 | 1,989 | $23K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 394 | 371 | $22K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 344 | 342 | $21K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,839 | 3,916 | $21K |
| 74018 | 1,136 | 1,104 | $20K | |
| A4217 | Sterile water/saline, 500 ml | 3,122 | 2,976 | $20K |
| 87070 | 1,580 | 1,547 | $19K | |
| 82948 | 2,401 | 2,114 | $19K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 837 | 812 | $17K |
| 87081 | 2,073 | 2,010 | $17K | |
| 71046 | Radiologic examination, chest; 2 views | 686 | 661 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | 80 | 80 | $15K |
| 87420 | 1,109 | 1,081 | $15K | |
| 85730 | 2,081 | 1,986 | $14K | |
| 0250 | 2,596 | 1,803 | $13K | |
| 85610 | 2,430 | 2,319 | $12K | |
| 0270 | 3,131 | 2,070 | $12K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 561 | 531 | $12K |
| 86901 | 2,074 | 1,967 | $11K | |
| 73564 | 355 | 349 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | 453 | 439 | $10K |
| 73562 | 406 | 395 | $10K | |
| 85379 | 635 | 613 | $9K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 3,740 | 3,600 | $9K |
| 0710 | 353 | 335 | $9K | |
| 87186 | 760 | 719 | $9K | |
| 29125 | 839 | 815 | $8K | |
| 99221 | 45 | 45 | $8K | |
| 86900 | 2,023 | 1,925 | $8K | |
| 93971 | 64 | 63 | $7K | |
| 83735 | 788 | 699 | $6K | |
| 0259 | 1,116 | 969 | $6K | |
| Z7610 | 377 | 322 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,266 | 4,753 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,873 | 3,639 | $5K |
| 82150 | 553 | 524 | $5K | |
| 86886 | 636 | 622 | $5K | |
| 76801 | 92 | 85 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,452 | 2,307 | $5K |
| Q0092 | Set-up portable x-ray equipment | 541 | 523 | $5K |
| 73080 | 163 | 154 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,084 | 1,055 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 94 | 86 | $4K |
| 88313 | 244 | 224 | $4K | |
| 73140 | 218 | 213 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,131 | 1,898 | $4K |
| 93976 | 14 | 14 | $4K | |
| 82550 | 409 | 387 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 150 | 141 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 44 | 40 | $3K |
| 88342 | 64 | 64 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,192 | 2,928 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,404 | 2,301 | $3K |
| 12001 | 171 | 170 | $2K | |
| 0011A | 67 | 65 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 12 | 12 | $2K |
| J2060 | Injection, lorazepam, 2 mg | 999 | 892 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | 54 | 54 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 242 | 221 | $2K |
| 71101 | 39 | 38 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 767 | 719 | $1K |
| 88312 | 90 | 89 | $1K | |
| 0012A | 32 | 32 | $1K | |
| 72100 | 38 | 38 | $1K | |
| 29515 | 105 | 104 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,641 | 2,314 | $1K |
| 10060 | 62 | 62 | $999.20 | |
| 73090 | 48 | 44 | $990.46 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | 102 | 89 | $960.04 |
| 12011 | 25 | 24 | $954.31 | |
| J7510 | Prednisolone oral, per 5 mg | 1,199 | 1,153 | $907.42 |
| 76830 | Ultrasound, transvaginal | 14 | 13 | $905.52 |
| 59025 | Fetal non-stress test | 60 | 52 | $764.14 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,078 | 1,065 | $755.84 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 41 | 34 | $738.89 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 12 | 12 | $570.36 |
| 74022 | 12 | 12 | $515.75 | |
| 12002 | 26 | 26 | $455.29 | |
| 43235 | 27 | 24 | $441.75 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 24 | 24 | $415.25 |
| 36415 | Collection of venous blood by venipuncture | 298 | 247 | $400.63 |
| 0301 | 12 | 12 | $398.46 | |
| 29130 | 52 | 52 | $386.04 | |
| 73502 | 13 | 13 | $385.81 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 74 | 72 | $345.36 |
| 73590 | 13 | 12 | $321.63 | |
| 81003 | 82 | 81 | $272.80 | |
| 87210 | 40 | 40 | $247.42 | |
| J1630 | Injection, haloperidol, up to 5 mg | 84 | 63 | $244.38 |
| 81000 | 43 | 37 | $206.03 | |
| 87077 | 24 | 17 | $179.88 | |
| 84100 | 29 | 28 | $165.85 | |
| 82553 | 15 | 12 | $165.64 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 16 | 14 | $140.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 43 | 42 | $133.48 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 28 | 25 | $92.17 |
| J2704 | Injection, propofol, 10 mg | 296 | 258 | $84.35 |
| 86140 | 14 | 13 | $81.13 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 15 | 13 | $68.02 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 258 | 245 | $57.98 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 12 | 12 | $27.28 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 125 | 121 | $17.62 |